CIR Circassia Group Plc

TIDMCIR

RNS Number : 1472O

Circassia Pharmaceuticals Plc

30 September 2019

For immediate release

Circassia Pharmaceuticals plc

Total Voting Rights Update

30(th) September 2019

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 375,179,199 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

-Ends-

 
 For further information, please contact: 
 
   Circassia Pharmaceuticals plc 
   Julien Cotta, Company Secretary      +44 (0) 1865 405560 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVREAENEDEDNEFF

(END) Dow Jones Newswires

September 30, 2019 06:06 ET (10:06 GMT)

Circassia (LSE:CIR)
Historical Stock Chart
From Mar 2024 to Apr 2024

Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2023 to Apr 2024